NSCI — Nanalysis Scientific Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Nanalysis Scientific, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	0.074	-1.66	-3.68	-1.77	-9.1
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	0.263	0.288	0.303	0.569	1.71
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-0.941	1.05	1.28	-2.56	-4.88
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	-0.17	0.781	-0.623	-1.2	-8.36
Capital Expenditures	-2.25	-3.14	-2.9	-3	-7.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	—	—	-1.21	-0.343	-4.53
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities	-2.25	-3.14	-4.11	-3.35	-11.7
Financing Cash Flow Items	0.015	6.23	0	10.2	13.9
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	2.09	8.2	1.27	11.8	13.2
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.326	5.84	-3.46	7.25	-6.88